calendar

2 catalysts · 1 phase 2 completion · 1 phase 3 initiation

next 91 dayslessmore

MonWedFri

view

sort

Pulmonology

3

Week of Apr 27, 2026

2

Apr 29, 2026phase 2 completion104d agoMassachusetts Eye and Ear Infirmary — N-acetylcysteine (Phase II Trial Completion)N-acetylcysteine

Therapy area: Ophthalmology. Indication: Cataract, Fuchs Endothelial Corneal Dystrophy (FECD)

Apr 29, 2026phase 3 initiation104d agoAll India Institute of Medical Sciences Bathinda — mitomycin (Phase III Trial Initiation)Jelmyto

Therapy area: Ophthalmology. Indication: Open-Angle Glaucoma